SEC ownership of CV Sciences, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001510964.

Comparable stake leader

Charlie E. Cheever III

Disclosed value leader

Charlie E. Cheever III

Comparable rows

1/9

Latest evidence

16 Jul 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
1 of 9
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Charlie E. Cheever III
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
16 Jul 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001510964
Issuer location
San Diego, CA

Ownership snapshot

Top shareholders of CV Sciences, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Charlie E. Cheever III
Disclosed value leader
Charlie E. Cheever III
Comparable rows
1/9
Latest evidence
16 Jul 2026
3/4/5 13D/G Lead comparable stake: 13% 8 rows are not safely comparable across share classes. 13D/G row: Charlie E. Cheever III Showing 1-8 of 9 holder rows.

Quick read

Charlie E. Cheever III leads the comparable SEC ownership view at 13%.

1 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Charlie E. Cheever III's linked filing trail.
Comparable ownership Top 1
Charlie E. Cheever III 13%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 9 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Charlie E. Cheever III
3/4/5 13D/G
10%+ Owner · CHEEVER CHARLIE E III
13%
from 13D/G
$2,477,737
27,530,411 shares
16 Jul 2026
Joseph D. Dowling
3/4/5
Chief Executive Officer, Director
class O/S missing
6,000,000 shares
18 Feb 2025
Joerg Grasser
3/4/5
Chief Financial Officer
class O/S missing
4,700,000 shares
18 Feb 2025
Joseph C. Maroon MD
3/4/5
Director
mixed-class rows
1,066,116 shares
mixed-class rows
02 Jun 2021
William McCorkle
3/4/5
Director
mixed-class rows
1,000,000 shares
mixed-class rows
18 Feb 2025
James Michael Corroon Jr.
3/4/5
Director
class O/S missing
500,000 shares
18 Feb 2025
Elizabeth Ann Altman
3/4/5
Director
class O/S missing
275,000 shares
02 Jun 2021
Paul Blake
3/4/5
Director
class O/S missing
275,000 shares
02 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 20 Sep 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-9 of 9 reporting-owner rows connected to CV Sciences, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
9
Largest Forms 3/4/5 holder
Charlie E. Cheever III
Net 12M change
$0
Latest report
16 Jul 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Charlie E. Cheever III 10%+ Owner $2,477,737 Market 16 Jul 2026
Elizabeth Ann Altman Director Mixed 02 Jun 2021
Terri F. Graham Director Mixed 02 Jun 2021
Paul Blake Director Mixed 02 Jun 2021
James Michael Corroon Jr. Director Mixed 18 Feb 2025
Joseph D. Dowling Chief Executive Officer, Director Mixed 18 Feb 2025
Joerg Grasser Chief Financial Officer Mixed 18 Feb 2025
Joseph C. Maroon MD Director Mixed 02 Jun 2021
William McCorkle Director Mixed 18 Feb 2025

Recent insider transactions for CV Sciences, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Charlie E. Cheever III CVSI Common Stock, $0.0001 par value per share Purchase 0.36% 94,854 26,648,711 07 Aug 2026 Direct
Charlie E. Cheever III CVSI Common Stock, $0.0001 par value per share Purchase 0.41% 108,000 26,553,857 04 Aug 2026 Direct
Charlie E. Cheever III CVSI Common Stock, $0.0001 par value per share Purchase 7% 1,730,000 26,445,857 31 Jul 2026 Direct
Charlie E. Cheever III CVSI Common Stock, $0.0001 par value per share Purchase 0.24% 60,000 24,715,857 29 Jul 2026 Direct
Charlie E. Cheever III CVSI Common Stock, $0.0001 par value per share Purchase 8.02% 1,830,000 24,655,857 28 Jul 2026 Direct
Charlie E. Cheever III CVSI Common Stock, $0.0001 par value per share Purchase 2.1% 470,075 22,825,857 24 Jul 2026 Direct
Charlie E. Cheever III CVSI Common Stock, $0.0001 par value per share Purchase 1.23% 272,500 22,355,782 22 Jul 2026 Direct
Charlie E. Cheever III CVSI Common Stock, $0.0001 par value per share Purchase 1.54% 335,000 22,083,282 21 Jul 2026 Direct
Charlie E. Cheever III CVSI Common Stock, $0.0001 par value per share Purchase 3.57% 749,000 21,748,282 17 Jul 2026 Direct
Charlie E. Cheever III CVSI Common Stock, $0.0001 par value per share Purchase 0.44% 91,387 20,999,282 16 Jul 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .